Testing effectiveness (Phase 2)Study completedNCT01189370
What this trial is testing
Evaluate Safety and Tolerability in Dose Escalation of Sorafenib in Advanced Renal Cell Cancer
Who this might be right for
Renal Cell Cancer
University of Kansas Medical Center 25